Showing results (1861-1870 of 3,794) with videos related to
Sort By:
Pageof 380
Oncoimmunology|May 4, 2016
Antibody targeting soluble NKG2D ligand sMIC refuels and invigorates the endogenous immune system to fight cancerJennifer WuOncoimmunology|May 4, 2016
Cell-penetrating peptides-the Swiss Army knife of cancer vaccinesPaul R Walker, Elodie Belnoue, Pierre-Yves Dietrich, et al.Oncoimmunology|May 4, 2016
Antitumor cytotoxicity induced by bone-marrow-derived antigen-presenting cells is facilitated by the tumor suppressor protein p53 via regulation of IL-12Tania L Slatter, Michelle Wilson, Chingwen Tang, et al.Oncoimmunology|May 4, 2016
G-CSF regulates macrophage phenotype and associates with poor overall survival in human triple-negative breast cancerMaija Hollmén, Sinem Karaman, Simon Schwager, et al.Oncoimmunology|May 4, 2016
Comparison of the prognostic value of measures of the tumor inflammatory cell infiltrate and tumor-associated stroma in patients with primary operable colorectal cancerJ H Park, D C McMillan, J Edwards, et al.Oncoimmunology|May 4, 2016
Prospective strategies to combine conventional, targeted and immunotherapies in non-small cell lung cancerDanila Valmori, Maha AyyoubOncoimmunology|May 4, 2016
Immunosuppressive parameters in serum of ovarian cancer patients change during the disease courseAn Coosemans, Judit Decoene, Thaïs Baert, et al.Oncoimmunology|May 4, 2016
Advances in clinical NK cell studies: Donor selection, manufacturing and quality controlU Koehl, C Kalberer, J Spanholtz, et al.Oncoimmunology|May 4, 2016
Deletion of LRP5 and LRP6 in dendritic cells enhances antitumor immunityYuan Hong, Indumathi Manoharan, Amol Suryawanshi, et al.Oncoimmunology|May 4, 2016
Tumor cell-derived microparticles polarize M2 tumor-associated macrophages for tumor progressionRuihua Ma, Tiantian Ji, Degao Chen, et al.Pageof 380